Tampere University has licensed a drug molecule intended for treating Epidermolysis Bullosa (EB), a group of rare and severe skin disorders, to Theravia, a pharmaceutical company headquartered in the ...

In a landmark move set to redefine medical education in Central Asia, Thumbay Group, a diversified international business ...

A novel approach developed by a UB physician-scientist and colleagues to cure hepatitis C virus in people with opioid use ...